|Title:||Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams|
|Abstract:||A stable budesonide solution with a pH not exceeding 6.0 in which the budesonide is dissolved in a solvent which may be water, an alcohol such as ethanol, isopropanol or propylene glycol, or a water/alcohol mixture. The solution preferably also contains a stabilizer such as sodium ethylenediaminetetraacetic acid, cyclodextrins or mixtures thereof. The stable budesonide solution is useful as the active ingredient in a rectal enema or a rectal foam.|
|Inventor(s):||Otterbeck; Norbert (Uberlingen, DE), Kuhn; Reimund (Freiamt, DE)|
|Assignee:||Dr. Falk Pharma GmbH (Freiburg, DE)|
Patent Claim Types:|
see list of patent claims
Field: Medical technology
Back Citations: 6th percentile
Forward Citations: 14th percentile
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Germany||44 46 891||Dec 27, 1994|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.